Goldcrest – Talk Bio

Actionable Insights Powered by AI

Novartis bolsters renal disease pipeline with $1.7B deal for Regulus

1 week ago talkbio0Tagged farabursen, Goldcrest, Novartis

Goldcrest, farabursen, Novartis

Novartis to buy Regulus Therapeutics for up to $1.7B

1 week ago talkbio0Tagged Acquisition (action), Goldcrest, Kidney Diseases, Novartis

Goldcrest, Novartis, Acquisition (action), Kidney Diseases